William Hait - 24 Oct 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Title: Chief External Innovation and Medical Safety Officer
Signature
Raavi Deol, as attorney-in-fact for William Hait
Issuer symbol
JNJ
Transactions as of
24 Oct 2022
Net transactions value
-$1,216,620
Form type
4
Filing time
26 Oct 2022, 16:51:02 UTC
Previous filing
25 Apr 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $1,356,600 +15,000 +19% $90.44 95,236 24 Oct 2022 Direct
transaction JNJ Common Stock Sale $203,627 -1,187 -1.2% $171.55 94,049 24 Oct 2022 Direct
transaction JNJ Common Stock Sale $2,369,593 -13,813 -15% $171.55 80,236 24 Oct 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -15,000 -51% $0.000000 14,698 24 Oct 2022 Common Stock 15,000 $90.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $171.52 to $171.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

Title: Chief External Innovation and Medical Safety Officer